Literature DB >> 31122216

Correction to: What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping review.

Marie-Pier Roussel1,2,3, Marika Morin1, Cynthia Gagnon2,3,4, Elise Duchesne5,6,7.   

Abstract

An incorrect attribution of the first study regarding the effect of exercise in DM1 mouse models needs to be revised.

Entities:  

Year:  2019        PMID: 31122216      PMCID: PMC6533645          DOI: 10.1186/s12891-019-2643-8

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


Correction to: BMC Musculoskelet Disord (2019) 20:101 https://doi.org/10.1186/s12891-019-2458-7

Abstract

An incorrect attribution of the first study regarding the effect of exercise in DM1 mouse models needs to be revised.

Main text

In this article, we cited Manta et al. 2019 [1] as the first study to publish about the effects of exercise in DM1 mouse models This was an oversight considering that Ravel-Chapuis et al. 2018 [2] have reported in the last part of their “Results” section, presentation of the effects of wheel running on skeletal muscles of their DM1 mouse model. This article was published in October 2018 while the article of Manta et al. 2019 [1] was published in January 2019.
  2 in total

1.  Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.

Authors:  Alexander Manta; Derek W Stouth; Donald Xhuti; Leon Chi; Irena A Rebalka; Jayne M Kalmar; Thomas J Hawke; Vladimir Ljubicic
Journal:  J Physiol       Date:  2019-01-30       Impact factor: 5.182

2.  Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles.

Authors:  Aymeric Ravel-Chapuis; Ali Al-Rewashdy; Guy Bélanger; Bernard J Jasmin
Journal:  Hum Mol Genet       Date:  2018-10-01       Impact factor: 6.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.